Delia Preti

Title: Delia Preti: Innovator in Pharmaceutical Compounds

Introduction

Delia Preti is a notable inventor based in Ferrara, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the adenosine A receptor. With a total of 2 patents, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

Delia Preti's latest patents include innovative compounds that serve as adenosine A receptor agonists. These compounds are designed for the treatment of diseases in mammals, including septic shock, cystic fibrosis, impotence, diarrhea, and cardiac diseases such as hyperplasia due to hypertension, arteriosclerosis, and heart attacks. Additionally, her inventions provide methods for inducing pharmacological stress to facilitate coronary imaging of ischemic areas. The compounds may also be labeled with radioactive isotopes for use in kinetic binding experiments. Another patent discloses a class of novel antagonists for the adenosine A receptor, which are useful as therapeutic and diagnostic agents for various medical conditions.

Career Highlights

Throughout her career, Delia Preti has worked with prominent organizations such as King Pharmaceuticals Research and Development, Inc. and Maria Cecilia Hospital S.p.a. Her expertise in pharmaceutical research has positioned her as a key figure in the development of innovative therapeutic agents.

Collaborations

Delia has collaborated with esteemed colleagues, including Pier Giovanni Baraldi and Pier Andrea Borea. These partnerships have further enhanced her research and contributions to the field.

Conclusion

Delia Preti's work in developing adenosine A receptor compounds showcases her innovative spirit and dedication to advancing medical science. Her patents reflect a commitment to addressing critical health issues, making her a significant contributor to the pharmaceutical industry.